申请人:Gilead Sciences, Inc.
公开号:US09145441B2
公开(公告)日:2015-09-29
Provided are compounds of Formula I:
and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.
所提供的是I式化合物及其药学上可接受的盐和酯。所提供的化合物、组合物和方法对于治疗病毒感染,特别是丙型肝炎感染,是有用的。